TOXICOLOGICAL ESTIMATION OF COMBINED ANTITUBERCULAR PREPARATION «PROTUB-2®»

TOXICOLOGICAL ESTIMATION OF COMBINED ANTITUBERCULAR PREPARATION «PROTUB-2®»

Toxicological research of combined antitubercular preparation. «Protub-2®» that contains a pyridoxine hydrochloride (vitamin B). It was established, that introduction of pyridoxine hydrochloride in the structure of preparation «Protub-2®» allowed to reduce the majority of toxic effects caused by iso...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. I. Usov, G. G. Yushkov, Yu. Yu. Schaura, A. S. Guschin
Format:	Article
Language:	Russian
Published:	Scientific Сentre for Family Health and Human Reproduction Problems 2012-07-01
Series:	Acta Biomedica Scientifica
Subjects:	antitubercular preparation isoniazid rifampicin pyridoxine hydrochloride (vitamin b<sub>6</sub>) toxicity xanthurenic acid
Online Access:	https://www.actabiomedica.ru/jour/article/view/1061
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Secreting Male Breast: A Clinical Oddity
by: Prashant Badole, et al.
Published: (2024-11-01)

ROLE OF PYRIDOXINE HYDROCHLORIDE IN THE DEVELOPMENT OF TOLERANCE TO THE TOXIC ACTION OF ISONIAZID IN ANIMALS
by: K. I. Usov, et al.
Published: (2018-07-01)

Acute toxicity of pyridoxine hydrochloride-containing and noncontaining antituberculosis drugs (an experimental study)
by: K. I. Usov, et al.
Published: (2014-12-01)

Experimental Substantiation of Taurine Use in Prophylaxis of Isoniazid-Induced Neurotoxic Reactions
by: G. N. Mozhokina, et al.
Published: (2020-05-01)

FORMATION OF RESPONSE OF RATS ORGANISM ON SINGLE INFLUENCE OF TERIZIDONE - 250 MG + PYRIDOXINE HYDROCHLORIDE - 10 MG
by: K. A. Badenikova, et al.
Published: (2012-07-01)

Mitigating Tuberculosis Drug-induced Liver Injury: The Role of Moringa oleifera and Other Herbal Extracts
by: Herin Mawarti, et al.
Published: (2025-04-01)

Challenges faced during antitubercular therapy
by: B. K. Likhitha, et al.
Published: (2024-07-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Determination Micro Spectrohotometric of Pyridoxine Hydrochloride and Nicotinamide via Derivative Spectrophotometry First and Second
by: Mohammed Qasim Al-Sammaraee, et al.
Published: (2023-02-01)

Rectal Administration of Rifampicin and Isoniazid Suppositories: An Alternative Approach for the Treatment of Tuberculosis in a Patient with Multiple Comorbidities
by: Ioana Munteanu, et al.
Published: (2025-05-01)

Effect of pyridoxine and isonicotinic acid hydrazide on the nervous system during tuberculosis treatment
by: Tatyana E. Tyulkova
Published: (2018-11-01)

Structural isomerisation affects the antitubercular activity of adamantyl-isoxyl adducts
by: Yucheng Lu, et al.
Published: (2025-12-01)

Sequential Dramatic Regrowth of a Lumbar Pedicle Post–Antitubercular Therapy
by: Saurabh Kumar Verma, et al.
Published: (2016-06-01)

Apoptosis-Inducing Action of Antituberculosis Drugs of the Main Group in Vitro
by: O. A. Vasilyeva, et al.
Published: (2020-05-01)

Hepatoprotective potential of Chrysin in a rat model of isoniazid- and rifampicin-induced hepatic injury: suppression of matrix metalloproteinase and transforming growth factor β
by: Deepa Mandlik, et al.
Published: (2025-01-01)

The recent advances in benzimidazole-based antimicrobials and antitubercular agents
by: Abdalrahman Tarek, et al.
Published: (2025-08-01)

Combination of Turmeric and Vitamin B<sub>6</sub> in Burning Mouth Syndrome: A Retrospective Single-Arm Study
by: Rayhana Aouididi, et al.
Published: (2024-09-01)

Second-line antitubercular agents and their adverse effects
by: Nagorni-Obradović Ljudmila, et al.
Published: (2006-01-01)

Embelin mitigates hepatotoxicity induced by isoniazid and rifampicin in rats
by: O. F. Mosa
Published: (2024-06-01)

Lived experiences of female patients aged 15-49 years undergoing treatment for multi-drug resistant tuberculosis (MDR-TB) in Lira Regional Referral Hospital, Uganda
by: Kizito Omona, et al.
Published: (2024-12-01)

Curcuma longa L. Prevents Hepatotoxicity Induced Isoniazid and Rifampicin: An Experiment in Wistar Rats Model
by: Putri Halleyana Rahman, et al.
Published: (2024-06-01)

EFFECTIVENESS OF REAL-TIME PCR FOR EXPRESS FIRST LINE DRUG SUSCEPTIBILITY TESTING OF TUBERCULOUS MYCOBACTERIA USING SPUTUM SAMPLES AND SURGICAL SPECIMENS OF LUNG TISSUE
by: Yu. S. Alyapkina, et al.
Published: (2019-01-01)

Direct detection from sputum for drug-resistant Mycobacterium tuberculosis using a CRISPR-Cas14a-based approach
by: Guohui Xiao, et al.
Published: (2025-04-01)

Evaluation of some toxicological parameters of Oxantel-, Pyrantel- and Praziquantel-based anthelmintic in tablet formulation for dogs and cats
by: G. B. Arisova
Published: (2024-05-01)

Knowledge, Attitude, and Practice Toward Antitubercular Agents Among Pulmonary Tuberculosis Patients in Southwestern China: A Cross-Sectional Study
by: Pi Y, et al.
Published: (2025-05-01)

Construction of Z-Scheme Heterojunction BiOCl/Bi<sub>2</sub>WO<sub>6</sub> for Visible-Light Photocatalytic Degradation of Tetracycline Hydrochloride
by: Hetian Zhang, et al.
Published: (2025-04-01)

Colorimetric Assay of Thiamine Hydrochloride in Pharmaceutical Preparations
by: Ahmad et al.
Published: (2019-12-01)

A comparative study of accuracy between gene Xpert (cartridge-based nucleic acid amplification test) and line probe assay in retreatment cases of sputum-positive pulmonary tuberculosis
by: Upendra Kumar, et al.
Published: (2025-07-01)

Study of the pharmacokinetics of antituberculosis drug Biomairin
by: Sh. A. Shomurotov, et al.
Published: (2018-11-01)

Drug-induced differential culturability in diverse strains of Mycobacterium tuberculosis
by: Valerie F. A. March, et al.
Published: (2025-01-01)

Evaluation of Effectiveness of a New Kit of Reagents for Detection of Mutations Associated with Drug Resistance of Tuberculous Mycobacteria to Rifampicin and Isoniazid, by PCR according to Evidences of Clinical Trials
by: Yu. L. Mikulovich, et al.
Published: (2023-08-01)

Risk factors for rifampicin-susceptible and isoniazid-resistant tuberculosis in adult patients with type 2 diabetes mellitus in Nanjing
by: Jing Guo, et al.
Published: (2025-03-01)

Non-nucleophilic base promoted synthesis of azo-linked oxazolone-pyrazole hybrids: Antimicrobial, antitubercular, anticancer evaluations and in-silico modeling insights
by: Bonny Y. Patel, et al.
Published: (2024-12-01)

Adverse events of tuberculosis preventive therapy among individuals with latent tuberculosis infection: A nationwide cohort study in South Korea
by: Sung-Hee Oh, et al.
Published: (2025-07-01)

Use of Dispersible Fixed-Dose Combinations in Chemotherapy of Drug Susceptible Tuberculosis: Results of the Observational Study
by: E. S. Nikitina, et al.
Published: (2024-10-01)

Development and validation of BCG vaccine‐induced novel granulomatous liver injury preclinical animal model
by: Swati Sharma, et al.
Published: (2025-05-01)

Exploring the structural aspects of alanine racemase enzyme for antitubercular drug discovery – a computational approach
by: Unni Jayaram, et al.
Published: (2025-02-01)

The Gut Microbiota‐Xanthurenic Acid‐Aromatic Hydrocarbon Receptor Axis Mediates the Anticolitic Effects of Trilobatin
by: Xiaoyu Wu, et al.
Published: (2025-03-01)

Efficient Tetracycline Hydrochloride Degradation by Urchin-Like Structured MoS<sub>2</sub>@CoFe<sub>2</sub>O<sub>4</sub> Derived from Steel Pickling Sludge via Peroxymonosulfate Activation
by: Jin Qi, et al.
Published: (2025-07-01)

Proteomic analysis of magnesium-dependent proteins and children's health
by: O. A. Gromova, et al.
Published: (2017-02-01)